{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T04:33:38Z","timestamp":1781930018452,"version":"3.54.5"},"reference-count":113,"publisher":"King Faisal Specialist Hospital and Research Centre","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Saudi Medicine"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.4103\/0256-4947.77502","type":"journal-article","created":{"date-parts":[[2011,3,8]],"date-time":"2011-03-08T15:46:57Z","timestamp":1299599217000},"page":"111-128","source":"Crossref","is-referenced-by-count":24,"title":["Updated Recommendations for the Diagnosis and Management of Osteoporosis: A Local Perspective"],"prefix":"10.5144","volume":"31","author":[{"given":"Hussein","family":"Raef","sequence":"first","affiliation":[{"name":"From the Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munira","family":"Al-Bugami","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakra","family":"Balharith","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Moawad","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"El-Shaker","sequence":"additional","affiliation":[{"name":"Department of Family Medicine and Polyclinics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneela","family":"Hussain","sequence":"additional","affiliation":[{"name":"Department of Family Medicine and Polyclinics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Al-Shaikh","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Al-Badawi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3134","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2004.242"},{"key":"e_1_3_1_3_2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF01623184","article-title":"Hip fractures in the elderly: A worldwide projection","volume":"2","author":"Cooper C","year":"1992","journal-title":"Osteoporos Int"},{"key":"e_1_3_1_4_2","doi-asserted-by":"crossref","unstructured":"NIH consensus development panel on osteoporosis prevention diagnosis and therapy. South Med J . 2001; 94 :569-73.","DOI":"10.1097\/00007611-200106000-00005"},{"key":"e_1_3_1_5_2","first-page":"S1","article-title":"Scientific advisory council of the osteoporosis society of Canada.2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada","volume":"167","author":"Brown JP","year":"2002","journal-title":"CMAJ"},{"key":"e_1_3_1_6_2","doi-asserted-by":"crossref","unstructured":"NIH Consensus Development Panel on Osteoporosis. JAMA . 2001; 285 :785-95.","DOI":"10.1001\/jama.285.6.785"},{"key":"e_1_3_1_7_2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10867-008-9115-y","article-title":"Bone architechture: Collagen structure and calcium\/phosphorus maps","volume":"34","author":"Tzaphlidou M","year":"2008","journal-title":"J Biol Phys"},{"key":"e_1_3_1_8_2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s198-002-8337-y","article-title":"Improving risk assessment: Hip geometry, bone mineral distribution and bone strength in hip fracture cases and controls.The Epos study","volume":"13","author":"Crabtree NJ","year":"2002","journal-title":"Osteoporosis Int"},{"key":"e_1_3_1_9_2","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1002\/art.20671","article-title":"Association of severe vertebral fractures with reduced quality of life","volume":"50","author":"Crans GG","year":"2004","journal-title":"Arthritis Rheum"},{"key":"e_1_3_1_10_2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00198-002-1316-9","article-title":"European Vertebral Osteoporosis Study. Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: A 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study","volume":"14","author":"Hasserius R","year":"2003","journal-title":"Osteoporosis Int"},{"key":"e_1_3_1_11_2","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1532-5415.2003.51110.x","article-title":"Estimating hip fracture morbidity, mortality, and costs","volume":"51","author":"Braithwaite RS","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"e_1_3_1_12_2","first-page":"283","article-title":"Osteoporosis in postmenopausal Saudi women using dual X-ray bone densitometry","volume":"20","author":"El-Desouki MI","year":"1999","journal-title":"Saudi Med J"},{"key":"e_1_3_1_13_2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s002239900652","article-title":"Bone mineral density of the spine and femur in healthy Saudi females: Relation to vitamin D status, pregnancy, and lactation","volume":"65","author":"Ghannam NN","year":"1999","journal-title":"Calci Tissue Int"},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s002230020015","article-title":"Bone density measured by dual-energy X absorptiometry in healthy Kuwaity women","volume":"68","author":"Dougherty G","year":"2001","journal-title":"Calcif Tissue Int"},{"key":"e_1_3_1_15_2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00198-004-1639-9","article-title":"Bone mineral density of the spine and femur in healthy Saudi Arabs","volume":"16","author":"Ardawi MS","year":"2005","journal-title":"Osteoporos Int"},{"key":"e_1_3_1_16_2","first-page":"27","article-title":"Incidence of fractures after the age of 50 years in the Lebanese population and implications in terms of osteoporosis","volume":"49","author":"Baddoura R","year":"2001","journal-title":"Rev Epidemiol Sante Publique"},{"key":"e_1_3_1_17_2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/BF00298585","article-title":"Incidence of proximal femur fracture in an urbanized community in Saudi Arabia","volume":"56","author":"Al-Nuaim AR","year":"1999","journal-title":"Calcif Tissue Int"},{"key":"e_1_3_1_18_2","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1359\/jbmr.2000.15.9.1856","article-title":"Hypovitaminosis D in a Sunny Country: Relation to Lifestyle and Bone Markers","volume":"15","author":"Gannag\u00e9-Yared MH","year":"2000","journal-title":"J Bone Miner Res"},{"key":"e_1_3_1_19_2","doi-asserted-by":"crossref","first-page":"E53","DOI":"10.1542\/peds.107.4.e53","article-title":"Hypovitaminosis D in schoolchildren","volume":"107","author":"El-Hajj Fuleihan G","year":"2001","journal-title":"Pediatrics"},{"key":"e_1_3_1_20_2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/pgmj.60.707.589","article-title":"Exposure to sunlight and vitamin D deficiency in Saudi Arabian women","volume":"60","author":"Fonseca V","year":"1984","journal-title":"Postgrad Med J"},{"key":"e_1_3_1_21_2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1203\/00006450-198408000-00013","article-title":"25-Hydroxyvitamin D and total calcium: Extraordinarily low plasma concentrations in Saudi mothers and their neonates","volume":"18","author":"Taha SA","year":"1984","journal-title":"Pediatr Res"},{"key":"e_1_3_1_22_2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.ejcn.1602056","article-title":"Low calcium and vitamin D intake in healthy children and adolescents and their correlates","volume":"59","author":"Salamoun MM","year":"2005","journal-title":"Eur j Clin nutri"},{"key":"e_1_3_1_23_2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1024\/0300-9831.75.4.281","article-title":"Dietary calcium and vitamin D intake in an adult Middle Eastern population: Food sources and relation to lifestyle and PTH","volume":"75","author":"Gannag\u00e9-Yared MH","year":"2005","journal-title":"Int J Vitam Nutr Res"},{"key":"e_1_3_1_24_2","first-page":"169","article-title":"Vitamin D metabolism is altered in Asians Indians in the southern united states","volume":"83","author":"Awumey EM","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_1_25_2","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1210\/jcem.86.3.7327","article-title":"A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: Baseline data from the multiple outcomes of raloxifene evaluation clinical trial","volume":"86","author":"Lips P","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_1_26_2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/BF03346273","article-title":"The effect of vitamin D status on the severity of bone disease and on the other features of primary hyperparathyroidism (pHPT) in a vitamin D deficient region","volume":"27","author":"Raef H","year":"2004","journal-title":"J Endocrinol Invest"},{"key":"e_1_3_1_27_2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-137-6-200209170-00015","article-title":"Screening for postmenopausal osteoporosis: A review of the evidence for the US. Preventive Service Task Force","volume":"137","author":"Nelson HD","year":"2002","journal-title":"Ann Intern Med"},{"key":"e_1_3_1_28_2","first-page":"862","article-title":"Changing perceptions in osteoporosis","volume":"318","author":"Wilkin TJ","year":"1999","journal-title":"BMJ"},{"key":"e_1_3_1_29_2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s001980170072","article-title":"An Assessment Tool for Predicting Risk in Postmenopausal Women","volume":"12","author":"Black DM","year":"2011","journal-title":"Osteoporos Int"},{"key":"e_1_3_1_30_2","unstructured":"Kanis JA . on behalf of the World Health Organisation Scientific Group. 2007 WHO publication. Assessment of osteoporosis at the primary health care level WHO Collaborating Centre for Metabolic Bone Diseases University of Sheffield (Available on request from the WHO Collaborating Centre or the IOF)."},{"key":"e_1_3_1_31_2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00198-007-0550-6","article-title":"Cost-effective osteoporosis treatment thresholds: The United States perspective","volume":"19","author":"Tosteson AN","year":"2008","journal-title":"Osteoporos Int"},{"key":"e_1_3_1_32_2","first-page":"1351","article-title":"Determination of osteoporosis risk factors using a multiple logistic regression model in postmenopausal Turkish women","volume":"26","author":"Akkus Z","year":"2005","journal-title":"Saudi Med J"},{"key":"e_1_3_1_33_2","first-page":"131","article-title":"Middle East and North Africa consensus on osteoporosis","volume":"7","author":"Maalouf G","year":"2007","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"e_1_3_1_34_2","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.bone.2006.11.016","article-title":"Vertebral fracture risk and impact of database selection on identifying elderly Lebanese with osteoporosis","volume":"40","author":"Baddoura R","year":"2007","journal-title":"Bone"},{"key":"e_1_3_1_35_2","doi-asserted-by":"crossref","unstructured":"U.S. Preventive Services Task Force Screening for osteoporosis in postmenopausal women: Recommendations and rationale. Ann Intern Med . 2002; 137 :526-8.","DOI":"10.7326\/0003-4819-137-6-200209170-00014"},{"key":"e_1_3_1_36_2","unstructured":"Clinicians guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation Last accessed on 2008 Available from: http:\/\/www.nof.org ."},{"key":"e_1_3_1_37_2","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1001\/jama.286.22.2815","article-title":"Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: Results from the national osteoporosis risk assessment","volume":"286","author":"Siris ES","year":"2001","journal-title":"JAMA"},{"key":"e_1_3_1_38_2","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1359\/JBMR.050609","article-title":"Indentification of Osteopenic Women at high risk of frature: The OFELY study","volume":"20","author":"Sornay-Rendu E","year":"2005","journal-title":"J Bone Miner Res"},{"key":"e_1_3_1_39_2","first-page":"743","article-title":"Premenopausal women and low bone density","volume":"52","author":"Khan AA","year":"2006","journal-title":"Can Fam Physcian"},{"key":"e_1_3_1_40_2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1385\/JCD:7:1:85","article-title":"Bone densitometry in premenopausal women","volume":"7","author":"Khan AA","year":"2004","journal-title":"J Clin Densitom"},{"key":"e_1_3_1_41_2","doi-asserted-by":"crossref","unstructured":"Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum . 2001; 44 :1496-503 American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.","DOI":"10.1002\/1529-0131(200107)44:7<1496::AID-ART271>3.0.CO;2-5"},{"key":"e_1_3_1_42_2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1365-2796.1998.00408.x","article-title":"A UK Consensus Group on management of glucocorticoid-induced osteoporosis: An update","volume":"244","author":"Eastell R","year":"1998","journal-title":"J Intern Med"},{"key":"e_1_3_1_43_2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00198-005-2032-z","article-title":"Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: A consensus document of the Belgian Bone Club","volume":"17","author":"Devogelaer JP","year":"2006","journal-title":"Osteoporos Int"},{"key":"e_1_3_1_44_2","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1056\/NEJMoa071408","article-title":"Teriparatide or Alendronate in glucocorticoid-induce osteoporosis","volume":"357","author":"Saag KG","year":"2007","journal-title":"NEJM"},{"key":"e_1_3_1_45_2","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(09)60250-6","article-title":"for the HORIZON investigators Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial","volume":"373","author":"Reid M","year":"2009","journal-title":"Lancet"},{"key":"e_1_3_1_46_2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00198-003-1426-z","article-title":"Osteoporosis after solid organ and bone marrow transplantation","volume":"14","author":"Cohen A","year":"2003","journal-title":"Osteoporos Int"},{"key":"e_1_3_1_47_2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0002-9343(98)00081-3","article-title":"Osteoporosis after organ transplantation","volume":"104","author":"Rodino MA","year":"1998","journal-title":"American Journal of Medicine"},{"key":"e_1_3_1_48_2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1513\/pats.200808-077GO","article-title":"Medical complications of lung transplantation","volume":"6","author":"Lyu DM","year":"2009","journal-title":"Proc Am Thorac Soc"},{"key":"e_1_3_1_49_2","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1359\/jbmr.040912","article-title":"Management of bone loss after organ transplantation","volume":"19","author":"Cohen A","year":"2004","journal-title":"J Bone Miner Res"},{"key":"e_1_3_1_50_2","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1359\/jbmr.2000.15.9.1818","article-title":"Effect of calcitriol on bone loss after cardiac or lung transplantation","volume":"15","author":"Sambrook P","year":"2000","journal-title":"J Bone and Mineral Res"},{"key":"e_1_3_1_51_2","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1097\/01.ASN.0000016082.70875.36","article-title":"Treatment with vitamin D and calcium reduces bone loss after renal transplantation: a randomized study","volume":"13","author":"De Sevaux RG","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"e_1_3_1_52_2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0140-6736(00)03641-2","article-title":"Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: A follow-up study","volume":"357","author":"Leidig-Bruckner G","year":"2001","journal-title":"Lancet"},{"key":"e_1_3_1_53_2","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/00007890-200110150-00012","article-title":"Prevention of bone loss and fracture after lung transplantation: A pilot study","volume":"72","author":"Cahill BC","year":"2001","journal-title":"Transplantation"},{"key":"e_1_3_1_54_2","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1097\/01.ASN.0000087092.53894.80","article-title":"Prevention of bone loss in renal transplant recipients: A prospective, randomized trial of intravenous pamidronate","volume":"14","author":"Coco M","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"e_1_3_1_55_2","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0041-1345(00)02464-7","article-title":"Prevention of bone loss in kidney graft recipients","volume":"33","author":"Kovac D","year":"2001","journal-title":"Transplant Proc"},{"key":"e_1_3_1_56_2","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1046\/j.1523-1755.2003.00816.x","article-title":"Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation","volume":"63","author":"Haas M","year":"2003","journal-title":"Kidney Int"},{"key":"e_1_3_1_57_2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00298990","article-title":"Calcitonin and bisphosphonates treatment in bone loss after liver transplantation","volume":"57","author":"Valero MA","year":"1995","journal-title":"Calcif Tissue Int"},{"key":"e_1_3_1_58_2","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/00007890-199810270-00007","article-title":"Treatment of osteopenia and osteoporosis after kidney transplantation","volume":"66","author":"Grotz WH","year":"1998","journal-title":"Transplantation"},{"key":"e_1_3_1_59_2","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1111\/j.1600-6143.2008.02327.x","article-title":"Effect of teriparatide onearly bone loss after kidney transplantation","volume":"8","author":"Cejka D","year":"2008","journal-title":"Am J Transplant"},{"key":"e_1_3_1_60_2","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/TP.0b013e318166ac10","article-title":"Serum testosterone levels after cardiac transplantation","volume":"85","author":"Fleischer J","year":"2008","journal-title":"Transplantation"},{"key":"e_1_3_1_61_2","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1378\/chest.109.5.1176","article-title":"Severe osteoporosis before and after lung transplantation","volume":"109","author":"Aris RM","year":"1996","journal-title":"Chest"},{"key":"e_1_3_1_62_2","first-page":"588","article-title":"Bone mass in patients with type 1 diabetes mellitus awaiting simultaneous pancreas kidney transplant","volume":"23","author":"Desso V","year":"1998","journal-title":"Bone"},{"key":"e_1_3_1_63_2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/TP.0b013e318176b40f","article-title":"Bisphosphonates and bone fractures in long-term kidney transplant recipients","volume":"08","author":"Conley E","year":"2008","journal-title":"Transplantation"},{"key":"e_1_3_1_64_2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1378\/chest.117.2.476","article-title":"Osteoporosis and lung transplantation: a prospective study","volume":"117","author":"Spira A","year":"2000","journal-title":"Chest"},{"key":"e_1_3_1_65_2","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/01.tp.0000177645.63999.ca","article-title":"Discontinuing antiresorptive therapy one year after cardiac transplantation: effect on bone density and bone turnover","volume":"81","author":"Cohen A","year":"2006","journal-title":"Transplantation"},{"key":"e_1_3_1_66_2","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.bone.2007.07.008","article-title":"Osteoporosis in children and adolescents","volume":"41","author":"Bianchi ML","year":"2007","journal-title":"Bone"},{"key":"e_1_3_1_67_2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/B978-012286551-0\/50019-1","volume-title":"Pediatric bone: Biology and diseases","author":"Ward LM","year":"2003"},{"key":"e_1_3_1_68_2","doi-asserted-by":"crossref","unstructured":"Bone density evaluation in teens prevents future osteoporosis. Arch Pediatr Adolesc Med . 2006; 160 :1026-32.","DOI":"10.1001\/archpedi.160.10.1026"},{"key":"e_1_3_1_69_2","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.berh.2005.06.006","article-title":"How to manage osteoporosis in children","volume":"19","author":"Bianchi ML","year":"2005","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"e_1_3_1_70_2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1210\/jc.2008-1531","article-title":"Clinical review 1: Bisphosphonate use in childhood osteoporosis","volume":"94","author":"Bachrach LK","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_1_71_2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/000992280003901001","article-title":"Adolescents: At Increased Risk for Osteoporosis?","volume":"39","author":"Cromer B","year":"2000","journal-title":"Clin Pediatr"},{"key":"e_1_3_1_72_2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF00297295","article-title":"Osteogenesis imperfecta: A clinical study of the first 10 years of life","volume":"50","author":"Vetter U","year":"1992","journal-title":"Calcif Tissue Int"},{"key":"e_1_3_1_73_2","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/00006254-200108000-00023","article-title":"Osteoporosis in children and adolescent girls: case report of idiopathic juvenile osteoporosis and review of the literature","volume":"56","author":"Kauffman RP","year":"2001","journal-title":"Obstet Gynecol Surv"},{"key":"e_1_3_1_74_2","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/1529-0131(200009)43:9<1960::AID-ANR6>3.0.CO;2-J","article-title":"Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: A prospective multicenter study","volume":"43","author":"Bianchi ML","year":"2000","journal-title":"Arthritis Rheum"},{"key":"e_1_3_1_75_2","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/adc.2003.036590","article-title":"Bisphosphonate treatment of bone disease","volume":"90","author":"Shaw NJ","year":"2005","journal-title":"Arch Dis Child"},{"key":"e_1_3_1_76_2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000497579","article-title":"Osteoporosis in Renal Failure: How accurate is the diagnosis and is there any role for bisphosphonates?","volume":"13","author":"Saadi H","year":"2005","journal-title":"Int J Diabetes Metab"},{"key":"e_1_3_1_77_2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.semnephrol.2009.01.007","article-title":"Diagnosis and Treatment of Osteoporosis in Chronic Renal Failure","volume":"29","author":"Miller PD","year":"2009","journal-title":"Semin Nephrol"},{"key":"e_1_3_1_78_2","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, Evaluation and Classification of Renal Osteodystrophy: A Position Statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe S","year":"2006","journal-title":"Kidney Int"},{"key":"e_1_3_1_79_2","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1359\/JBMR.050817","article-title":"Safety and Efficacy of Risdronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: A pooled analysis of nine clinical trials","volume":"20","author":"Miller PD","year":"2005","journal-title":"J Bone Mineral Res"},{"key":"e_1_3_1_80_2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1359\/jbmr.070112","article-title":"Alendronate treatment in women with normal to severely impaired renal function: An analysis for the fracture intervention trial","volume":"22","author":"Jamal SA","year":"2007","journal-title":"J Bone Mineral Res"},{"key":"e_1_3_1_81_2","first-page":"1430","article-title":"MORE investigators.The effect of Raloxifene treatment in post-menopausal women with CKD","volume":"19","author":"Ishani A","year":"2008","journal-title":"J Am Sco Nehprol"},{"key":"e_1_3_1_82_2","article-title":"Diagnosis and Treatment of Osteoporosis or fragility fractures in patients with Chronic Kidney Disease.Osteoporosis: Clinical Update- National Osteoporosis Foundation","author":"Miller PD","year":"2005","journal-title":"Summer"},{"key":"e_1_3_1_83_2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7326\/0003-4819-148-3-200802050-00198","article-title":"Systematic review: Comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis","volume":"148","author":"MacLean C","year":"2008","journal-title":"Ann Intern Med"},{"key":"e_1_3_1_84_2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00198-008-0560-z","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"19","author":"Kanis JA","year":"2008","journal-title":"Osteoporos Int"},{"key":"e_1_3_1_85_2","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/er.2001-9002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis","volume":"23","author":"Cranney A","year":"2002","journal-title":"Endocr Rev"},{"key":"e_1_3_1_86_2","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00198-005-1945-x","article-title":"Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies","volume":"16","author":"Boonen S","year":"2005","journal-title":"Osteoporos Int"},{"key":"e_1_3_1_87_2","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial: Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators","volume":"282","author":"Ettinger B","year":"1999","journal-title":"JAMA"},{"key":"e_1_3_1_88_2","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S8756-3282(03)00241-2","article-title":"Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: Results from the MORE trial","volume":"33","author":"Delmas PD","year":"2003","journal-title":"Bone"},{"key":"e_1_3_1_89_2","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial","volume":"295","author":"Vogel VG","year":"2006","journal-title":"JAMA"},{"key":"e_1_3_1_90_2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","article-title":"Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women","volume":"355","author":"Barrett-Connor E","year":"2006","journal-title":"N Engl J Med"},{"key":"e_1_3_1_91_2","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures: Fracture Intervention Trial Research Group","volume":"348","author":"Black DM","year":"1996","journal-title":"Lancet"},{"key":"e_1_3_1_92_2","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: Results from the Fracture Intervention Trial","volume":"280","author":"Cummings SR","year":"1998","journal-title":"JAMA"},{"key":"e_1_3_1_93_2","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial: Vertebral Efficacy with Risedronate Therapy (VERT) Study Group","volume":"282","author":"Harris ST","year":"1999","journal-title":"JAMA"},{"key":"e_1_3_1_94_2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women: Hip Intervention Program Study Group","volume":"344","author":"McClung MR","year":"2001","journal-title":"N Engl J Med"},{"key":"e_1_3_1_95_2","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1359\/JBMR.040325","article-title":"Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis","volume":"19","author":"Chesnut IC","year":"2004","journal-title":"J Bone Miner Res"},{"key":"e_1_3_1_96_2","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s00198-004-1602-9","article-title":"Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: Results from the BONE study","volume":"15","author":"Delmas PD","year":"2004","journal-title":"Osteoporos Int"},{"key":"e_1_3_1_97_2","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/ard.2005.044958","article-title":"Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study","volume":"65","author":"Reginster JY","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"e_1_3_1_98_2","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1002\/art.21918","article-title":"Intravenous ibandronate injections in postmenopausal women with osteoporosis: One-year results from the dosing intravenous administration study","volume":"54","author":"Delmas PD","year":"2006","journal-title":"Arthritis Rheum"},{"key":"e_1_3_1_99_2","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black DM","year":"2007","journal-title":"N Engl J Med"},{"key":"e_1_3_1_100_2","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","article-title":"The HORIZON Recurrent Fracture Trial: Zoledronic acid and clinical fractures and mortality after hip fracture","volume":"357","author":"Lyles KW","year":"2007","journal-title":"N Engl J Med"},{"key":"e_1_3_1_101_2","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer RM","year":"2001","journal-title":"N Engl J Med"},{"key":"e_1_3_1_102_2","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1345\/aph.1G146","article-title":"Parathyroid hormone (1-84) and treatment of osteoporosis","volume":"39","author":"Ahrader SP","year":"2005","journal-title":"Ann Pharmacother"},{"key":"e_1_3_1_103_2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","article-title":"The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis","volume":"350","author":"Meunier PJ","year":"2004","journal-title":"N Engl J Med"},{"key":"e_1_3_1_104_2","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/art.23461","article-title":"Effects of long term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis, results of five year, randomizes, placebo-controlled trial","volume":"58","author":"Reginster JY","year":"2008","journal-title":"Arthritis and Rheumatism"},{"key":"e_1_3_1_105_2","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1210\/jc.2004-1774","article-title":"Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study","volume":"90","author":"Reginster JY","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_1_106_2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/1573397052954163","article-title":"Is there any interest in combining treatments in osteoporosis?","volume":"1","author":"Rabenda V","year":"2005","journal-title":"Curr Rheumatol Rev"},{"key":"e_1_3_1_107_2","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","article-title":"The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis","volume":"249","author":"Black DM","year":"2003","journal-title":"New Engl J Med"},{"key":"e_1_3_1_108_2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa050336","article-title":"One year alendronate after one year of parathyroid hormone (1-84) for osteoporosis","volume":"353","author":"Black DM","year":"2005","journal-title":"N Engl J Med"},{"key":"e_1_3_1_109_2","doi-asserted-by":"crossref","unstructured":"Writing Group for the Women's Health Initiative Investigators. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women. JAMA . 2002; 288 :321-33.","DOI":"10.1001\/jama.288.3.321"},{"key":"e_1_3_1_110_2","doi-asserted-by":"crossref","unstructured":"Writing Group for the Heart and Estrogen\/ progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in post menopausal women. JAMA . 1998; 280 :605-18.","DOI":"10.1001\/jama.280.7.605"},{"key":"e_1_3_1_111_2","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1056\/NEJM199302183280702","article-title":"Effect of Calcium Supplementation on Bone Loss in Postmenopausal Women","volume":"328","author":"Reid IR","year":"1993","journal-title":"N Engl J Med"},{"key":"e_1_3_1_112_2","first-page":"CD000227","article-title":"Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis","volume":"1","author":"Gillepsie WJ","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_1_113_2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9343(00)00490-3","article-title":"A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: The PROOF study","volume":"109","author":"Chestnut CH","year":"2000","journal-title":"Am J Med"},{"key":"e_1_3_1_114_2","first-page":"2","article-title":"New and Emerging Treatment for osteoporosis","volume":"3","author":"Clarke B","year":"2008","journal-title":"Mayo Clinic Endocrinology Update"}],"container-title":["Annals of Saudi Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T17:14:06Z","timestamp":1685985246000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.annsaudimed.net\/doi\/10.4103\/0256-4947.77502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":113,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["10.4103\/0256-4947.77502"],"URL":"https:\/\/doi.org\/10.4103\/0256-4947.77502","relation":{},"ISSN":["0256-4947","0975-4466"],"issn-type":[{"value":"0256-4947","type":"print"},{"value":"0975-4466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}